MedPath
HSA Approval

CLEANCEF CAPSULE 250 mg

SIN09294P

CLEANCEF CAPSULE 250 mg

CLEANCEF CAPSULE 250 mg

April 10, 1997

ZYFAS PHARMA PTE LTD

ZYFAS PHARMA PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantZYFAS PHARMA PTE LTD
Licence HolderZYFAS PHARMA PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

CAPSULE

ORAL

Medical Information

J01DC04

cefaclor

Manufacturer Information

ZYFAS PHARMA PTE. LTD.

SHIN POONG PHARMACEUTICAL CO LTD

Active Ingredients

CEFACLOR (POTENCY)

250 mg

Cefaclor

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

CLEANCEF CAPSULE 250 mg - HSA Approval | MedPath